Iterum Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on May 14, 2021 May 7, 2021
Iterum Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on March 12, 2021 Mar 5, 2021
Iterum Therapeutics plc Announces Exercise of Underwriter’s Option to Purchase Additional Ordinary Shares Feb 10, 2021
Iterum Therapeutics plc Announces $35.0 Million Registered Direct Offering of Ordinary Shares Priced At-the-Market under Nasdaq Rules Feb 9, 2021
Iterum Therapeutics plc Increases Previously Announced Bought Deal Public Offering of Ordinary Shares to $40.0 Million Feb 3, 2021
Iterum Therapeutics plc Announces $10 Million Bought Deal Public Offering of Ordinary Shares Feb 3, 2021
